Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_assertion type Assertion NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_head.
- NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_provenance.
- NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_assertion evidence source_evidence_literature NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_provenance.
- NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_assertion SIO_000772 8558940 NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_provenance.
- NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_assertion wasDerivedFrom befree-20150227 NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_provenance.
- NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_assertion wasGeneratedBy ECO_0000203 NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_provenance.